Paúl E. Clavijo

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 270 citations · Full text

Medicine, Immunology, Oncology +16

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 232 citations · Full text

Medicine, Immunology, Oncology +17

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ

Ruth J. Davis, Ellen Moore, Paúl E. Clavijo et al. · Cancer Research · 2017 · 209 citations

Medicine, Immunology, Pharmacology +15

Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors

Tadanobu Nagaya, Jay Friedman, Yasuhiro Maruoka et al. · Cancer Immunology Research · 2019 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17

Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade

Ellen Moore, Paúl E. Clavijo, Ruth J. Davis et al. · Cancer Immunology Research · 2016 · 153 citations · Full text

Life Sciences, Immunology, Oncology +17